Keyphrases
Direct-acting Antiviral Treatment
100%
HCV Resistance
100%
Long-term Persistence
100%
Resistance-associated Substitutions
100%
Treatment Failure
100%
GT1b
27%
NS5B
22%
Direct-acting Antivirals
16%
NS5A
16%
HCV Elimination
11%
End of Treatment
11%
Elimination Goals
11%
Retreatment
11%
Direct-acting Antiviral Failure
11%
Clinical Parameters
5%
Limited Availability
5%
General Rules
5%
Protease Inhibitors
5%
Virologic
5%
Least Developed Countries
5%
NS5A Inhibitor
5%
Q80K
5%
HCV Genotype 3
5%
Treatment Resistance
5%
HCV Genotype 1
5%
S282T
5%
Rescue Treatment
5%
HCV Subtype
5%
Unnatural nucleotides
5%
Little Data
5%
HCV Retreatment
5%
Agricultural and Biological Sciences
Protease
100%
Genotyping
100%
Nucleoside
100%
Biochemistry, Genetics and Molecular Biology
NS5B
100%
NS5A
100%
Genotyping
25%
Protease Inhibitor
25%
Nucleoside
25%
Earth and Planetary Sciences
Less Developed Country
100%
Protease
100%
Immunology and Microbiology
NS5B
100%
NS5A
75%
NS5A Inhibitors
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antiviral Drug
100%
Elimination
25%
Nonstructural Protein 5A Inhibitor
12%
Infection
12%
Proteinase Inhibitor
12%
Nucleoside
12%